An unvaccinated New Mexico resident tested positive for measles upon undergoing a medical examination after dying, but ...

Despite high R&D spending and cash burn, Moderna aims for breakeven by 2028, driven by new vaccine opportunities. Explore ...

From 2008 to 2022, the incidence of cervical precancers fell by 80% among screened women aged 20 to 24 years, supporting ...

Moderna, Inc. (NASDAQ:MRNA) shares rose for a second day on Wednesday, adding 15.94 percent to finish at $35.21 apiece as ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

Senators challenged Jay Bhattacharya, MD, PhD, President Donald Trump's pick to lead the National Institutes of Health (NIH), ...

The S&P 500 advanced 1.1% on Wednesday, March 5, as the White House announced it would delay tariffs affecting U.S.

President Donald Trump’s pick to lead the National Institutes of Health answered sharp questions in a confirmation hearing ...

A University of Otago, Christchurch-led study is heralding the success of the HPV vaccination program, saying the cost and ...

New treatments for graft-vs.-host disease, updated dosage for HPV vaccines — and Fred Hutch announces awards for graduate students.

Moderna (MRNA) stock in focus as the company aims a 2027 marketing nod for Merck (MRK) partnered skin cancer vaccine. Read ...